SAGE
SAGE Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of SAGE by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Ro Khanna House / D | Purchase $1,001 - $15,000 | Nov 03, 2020 |
SAGE Stock Insider Trading Activity
Follow @QuiverQuant for major insider updates
---
Closing Price
Purchase
Sale
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
SAGE Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
SAGE Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in SAGE holdings by institutional investors
Quarterly net insider trading by SAGE's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Backtest Start Date
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Subscribe to Quiver Premium for insider trading alerts
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$50,000 Oct 20, 2025 Issue: Health Issues
-
$50,000 Jul 18, 2025 Issue: Health Issues
-
$50,000 Apr 18, 2025 Issue: Health Issues
-
$170,000 Jan 10, 2025 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
-
$120,000 Oct 18, 2024 Issue: Medicare/Medicaid Health Issues
-
$140,000 Jul 19, 2024 Issue: Medicare/Medicaid Health Issues
-
$110,000 Jan 19, 2024 Issue: Medicare/Medicaid Health Issues
-
$140,000 Oct 18, 2023 Issue: Medicare/Medicaid Health Issues
-
$130,000 Jul 19, 2023 Issue: Medicare/Medicaid Health Issues
-
$110,000 Jan 19, 2023 Issue: Medicare/Medicaid Health Issues
-
$120,000 Oct 20, 2022 Issue: Medicare/Medicaid Health Issues
-
$284,000 Oct 19, 2022 Issue: Medicare/Medicaid Health Issues
-
$197,756 Apr 19, 2022 Issue: Medicare/Medicaid Health Issues
-
$197,756 Jan 20, 2022 Issue: None
-
$275,000 Oct 22, 2021 Issue: None
-
$275,000 Jul 20, 2021 Issue: None
-
$287,000 Apr 20, 2021 Issue: None
-
$223,000 Jan 20, 2021 Issue: None
-
$287,000 Oct 19, 2020 Issue: None
-
$166,315 Jul 20, 2020 Issue: HEALTH ISSUES
-
$218,437 Apr 22, 2020 Issue: HEALTH ISSUES
-
$229,013 Jan 21, 2020 Issue: HEALTH ISSUES
-
$206,000 Oct 21, 2019 Issue: Health Issues
-
$154,000 Jul 22, 2019 Issue: Health Issues Copyright/Patent/Trademark
-
$50,000 Apr 22, 2019 Issue: Health Issues
-
$50,000 Jan 22, 2019 Issue: Health Issues
-
$50,000 Oct 16, 2018 Issue: Health Issues
-
$50,000 Jul 20, 2018 Issue: Health Issues
-
$30,000 Apr 19, 2018 Issue: Health Issues
-
$10,000 Oct 17, 2012 Issue: Defense Medical/Disease Research/Clinical Labs
-
$30,000 Jul 12, 2012 Issue: Medical/Disease Research/Clinical Labs Defense
-
$30,000 Apr 16, 2012 Issue: Medical/Disease Research/Clinical Labs Defense
-
$30,000 Jan 10, 2012 Issue: Medical/Disease Research/Clinical Labs Defense
-
$30,000 Oct 12, 2011 Issue: Defense Medical/Disease Research/Clinical Labs
-
$30,000 Jul 16, 2011 Issue: Defense Medical/Disease Research/Clinical Labs
-
$20,000 Apr 18, 2011 Issue: Medical/Disease Research/Clinical Labs Defense
Former government officials who have lobbied for SAGE
SAGE Estimated quarterly lobbying spending
SAGE Revenue by Segment or Geography
By Segment
By Geography
SAGE Income Statement
SAGE Balance Sheet
SAGE Cash Flow
U.S. Patents
New SAGE patent grants
-
Patent Title: Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of cns disorders Jul. 21, 2026
-
Patent Title: Neuroactive steroids and their methods of use Jul. 07, 2026
-
Patent Title: C17, c20, and c21 substituted neuroactive steroids and their methods of use Jun. 16, 2026
-
Patent Title: Neuroactive steroids and methods of use thereof May. 05, 2026
-
Patent Title: Compositions and methods for treating cns disorders Feb. 17, 2026
-
Patent Title: Oxysterols and methods of use thereof Oct. 21, 2025
-
Patent Title: Compositions and methods for treating cns disorders Sep. 23, 2025
-
Patent Title: Neuroactive steroids and their methods of use Sep. 09, 2025
-
Patent Title: Crystalline 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid Jul. 15, 2025
-
Patent Title: C7 substituted oxysterols and methods of use thereof Jun. 17, 2025
-
Patent Title: Oxysterols and methods of use thereof Apr. 08, 2025
-
Patent Title: Neuroactive steroids and their methods of use Apr. 01, 2025
-
Patent Title: Neuroactive steroids and their methods of use Mar. 18, 2025
-
Patent Title: 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof Jan. 21, 2025
-
Patent Title: Compositions and methods for treating cns disorders Dec. 31, 2024
-
Patent Title: Oxysterols and methods of use thereof Dec. 31, 2024
-
Patent Title: Oxysterols and methods of use thereof Oct. 29, 2024
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Oct. 29, 2024
-
Patent Title: Crystalline forms of a neuroactive steroid Oct. 22, 2024
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Sep. 10, 2024
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Aug. 27, 2024
-
Patent Title: Compositions and methods for treating cns disorders Aug. 20, 2024
-
Patent Title: Compositions and methods for treating cns disorders Aug. 13, 2024
-
Patent Title: Methods of treating epilepsy or status epilepticus Jul. 30, 2024
-
Patent Title: Neuroactive steroids and their methods of use Jun. 04, 2024
-
Patent Title: C7, c12, and c16 substituted neuroactive steroids and their methods of use May. 28, 2024
-
Patent Title: Neuroactive steroids and their methods of use Apr. 30, 2024
-
Patent Title: Crystalline forms of a neuroactive steroid Apr. 09, 2024
-
Patent Title: Compositions and methods for treating cns disorders Apr. 02, 2024
-
Patent Title: C7 substituted oxysterols and methods of use thereof Mar. 12, 2024
-
Patent Title: Neuroactive steroids and their methods of use Feb. 27, 2024
-
Patent Title: Neuroactive steroids and methods of use thereof Feb. 20, 2024
-
Patent Title: Oxysterols and methods of use thereof Jan. 30, 2024
-
Patent Title: Crystalline 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid Jan. 30, 2024
-
Patent Title: Oxysterols and methods of use thereof Jan. 23, 2024
-
Patent Title: Oxysterols and methods of use thereof Dec. 26, 2023
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Oct. 10, 2023
-
Patent Title: Oxysterols and methods of use thereof Aug. 22, 2023
-
Patent Title: Compositions and methods for treating cns disorders Aug. 08, 2023
-
Patent Title: Compositions and methods for treating cns disorders Jun. 06, 2023
-
Patent Title: Neuroactive steroids and compositions thereof May. 09, 2023
-
Patent Title: Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of cns disorders Apr. 25, 2023
-
Patent Title: Oxysterols and methods of use thereof Mar. 28, 2023
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Jan. 17, 2023
-
Patent Title: Compositions and methods for treating cns disorders Jan. 03, 2023
-
Patent Title: Compositions and methods for treating cns disorders Dec. 20, 2022
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Nov. 15, 2022
-
Patent Title: 19-nor c3, 3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof Aug. 08, 2017
-
Patent Title: 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof Dec. 06, 2016
-
Patent Title: 19-nor neuroactive steroids and methods of use thereof Jun. 14, 2016
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded to SAGE from public contracts
SAGE News
Recent insights relating to SAGE
CNBC Recommendations
Recent picks made for SAGE stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SAGE
SAGE Analyst Ratings
SAGE Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
SAGE Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $SAGE stock a Buy, Sell, or Hold?
- What is the price target for $SAGE stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
SAGE Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $SAGE stock?
- Who owns the most shares of $SAGE stock?
- What funds own $SAGE stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
SAGE Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SAGE Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
About SAGE
No description available
SAGE (SAGE) Historical Stock Prices
SAGE (SAGE) closed at $8.68 on July 30, 2025. Over the past year its adjusted close ranged from $4.78 to $10.95. Daily prices go back to July 18, 2014, 2,774 trading days in all.
- 1 month-4.82%
- 3 months+19.07%
- Year to date+59.85%
- 1 year-19.63%
- 3 years-74.77%
- 5 years-80.95%
- Max-71.16%
See every congressional and insider trade on the SAGE price chart
Quiver Premium charts SAGE's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|---|---|---|---|---|---|
| Jul 30, 2025 | 8.74 | 8.74 | 8.68 | 8.68 | 8.68 | 22,698,684 |
| Jul 29, 2025 | 8.76 | 8.77 | 8.70 | 8.70 | 8.70 | 7,383,558 |
| Jul 28, 2025 | 8.80 | 8.81 | 8.77 | 8.78 | 8.78 | 4,624,892 |
| Jul 25, 2025 | 8.79 | 8.82 | 8.76 | 8.80 | 8.80 | 2,933,621 |
| Jul 24, 2025 | 8.75 | 8.79 | 8.75 | 8.76 | 8.76 | 1,988,213 |
| Jul 23, 2025 | 8.78 | 8.80 | 8.71 | 8.77 | 8.77 | 2,648,135 |
| Jul 22, 2025 | 8.84 | 8.86 | 8.74 | 8.75 | 8.75 | 10,965,392 |
| Jul 21, 2025 | 9.08 | 9.11 | 8.96 | 8.97 | 8.97 | 2,079,785 |
| Jul 18, 2025 | 9.16 | 9.17 | 9.10 | 9.11 | 9.11 | 1,937,777 |
| Jul 17, 2025 | 9.16 | 9.16 | 9.12 | 9.14 | 9.14 | 1,137,855 |
| Jul 16, 2025 | 9.18 | 9.19 | 9.11 | 9.13 | 9.13 | 1,623,676 |
| Jul 15, 2025 | 9.16 | 9.19 | 9.10 | 9.17 | 9.17 | 1,068,322 |
| Jul 14, 2025 | 9.19 | 9.23 | 9.10 | 9.15 | 9.15 | 2,231,022 |
| Jul 11, 2025 | 9.19 | 9.36 | 9.13 | 9.27 | 9.27 | 3,064,296 |
| Jul 10, 2025 | 9.18 | 9.25 | 9.15 | 9.21 | 9.21 | 1,545,676 |
| Jul 9, 2025 | 9.19 | 9.24 | 9.14 | 9.20 | 9.20 | 1,393,818 |
| Jul 8, 2025 | 9.10 | 9.20 | 9.10 | 9.16 | 9.16 | 1,888,173 |
| Jul 7, 2025 | 9.15 | 9.20 | 9.11 | 9.17 | 9.17 | 1,458,883 |
| Jul 3, 2025 | 9.12 | 9.22 | 9.11 | 9.20 | 9.20 | 3,011,754 |
| Jul 2, 2025 | 9.06 | 9.17 | 9.06 | 9.08 | 9.08 | 1,482,753 |
| Jul 1, 2025 | 9.07 | 9.13 | 9.05 | 9.08 | 9.08 | 858,722 |
| Jun 30, 2025 | 9.15 | 9.18 | 9.04 | 9.12 | 9.12 | 2,723,329 |
| Jun 27, 2025 | 9.26 | 9.28 | 9.13 | 9.15 | 9.15 | 4,675,472 |
| Jun 26, 2025 | 9.21 | 9.29 | 9.18 | 9.28 | 9.28 | 930,050 |
| Jun 25, 2025 | 9.19 | 9.26 | 9.15 | 9.25 | 9.25 | 1,052,967 |
| Jun 24, 2025 | 9.28 | 9.30 | 9.15 | 9.22 | 9.22 | 1,287,083 |
| Jun 23, 2025 | 9.26 | 9.30 | 9.18 | 9.30 | 9.30 | 1,788,577 |
| Jun 20, 2025 | 9.19 | 9.30 | 9.12 | 9.30 | 9.30 | 2,600,519 |
| Jun 18, 2025 | 9.12 | 9.33 | 9.11 | 9.13 | 9.13 | 2,902,712 |
| Jun 17, 2025 | 9.05 | 9.14 | 9.03 | 9.12 | 9.12 | 4,129,712 |
| Jun 16, 2025 | 9.09 | 9.15 | 8.96 | 9.07 | 9.07 | 27,629,683 |
| Jun 13, 2025 | 6.52 | 6.72 | 6.44 | 6.70 | 6.70 | 647,392 |
| Jun 12, 2025 | 6.74 | 6.74 | 6.56 | 6.60 | 6.60 | 421,188 |
| Jun 11, 2025 | 7.06 | 7.21 | 6.71 | 6.77 | 6.77 | 485,907 |
| Jun 10, 2025 | 6.86 | 7.11 | 6.80 | 6.99 | 6.99 | 876,293 |
| Jun 9, 2025 | 6.95 | 6.95 | 6.71 | 6.81 | 6.81 | 374,846 |
| Jun 6, 2025 | 6.82 | 6.90 | 6.61 | 6.85 | 6.85 | 772,671 |
| Jun 5, 2025 | 6.53 | 6.96 | 6.50 | 6.78 | 6.78 | 900,047 |
| Jun 4, 2025 | 6.53 | 6.67 | 6.51 | 6.54 | 6.54 | 534,865 |
| Jun 3, 2025 | 6.63 | 6.72 | 6.49 | 6.53 | 6.53 | 699,860 |
| Jun 2, 2025 | 6.46 | 6.68 | 6.38 | 6.62 | 6.62 | 846,154 |
| May 30, 2025 | 6.46 | 6.53 | 6.35 | 6.46 | 6.46 | 612,245 |
| May 29, 2025 | 6.50 | 6.59 | 6.46 | 6.52 | 6.52 | 736,467 |
| May 28, 2025 | 6.52 | 6.60 | 6.46 | 6.48 | 6.48 | 673,816 |
| May 27, 2025 | 6.60 | 6.78 | 6.49 | 6.52 | 6.52 | 806,737 |
| May 23, 2025 | 6.54 | 6.60 | 6.50 | 6.53 | 6.53 | 770,577 |
| May 22, 2025 | 6.80 | 6.82 | 6.59 | 6.61 | 6.61 | 716,527 |
| May 21, 2025 | 7.12 | 7.13 | 6.78 | 6.80 | 6.80 | 614,217 |
| May 20, 2025 | 7.07 | 7.25 | 6.95 | 7.13 | 7.13 | 871,097 |
| May 19, 2025 | 6.84 | 7.10 | 6.84 | 7.07 | 7.07 | 785,371 |
| May 16, 2025 | 6.61 | 6.93 | 6.55 | 6.89 | 6.89 | 734,613 |
| May 15, 2025 | 6.52 | 6.62 | 6.37 | 6.61 | 6.61 | 666,630 |
| May 14, 2025 | 6.58 | 6.61 | 6.36 | 6.38 | 6.38 | 965,767 |
| May 13, 2025 | 6.79 | 6.80 | 6.58 | 6.61 | 6.61 | 877,856 |
| May 12, 2025 | 6.76 | 6.85 | 6.63 | 6.75 | 6.75 | 706,487 |
| May 9, 2025 | 6.73 | 6.89 | 6.50 | 6.56 | 6.56 | 997,942 |
| May 8, 2025 | 6.97 | 7.00 | 6.70 | 6.71 | 6.71 | 817,747 |
| May 7, 2025 | 7.09 | 7.09 | 6.78 | 6.82 | 6.82 | 596,181 |
| May 6, 2025 | 7.13 | 7.14 | 6.83 | 6.86 | 6.86 | 1,566,565 |
| May 5, 2025 | 7.28 | 7.36 | 7.13 | 7.17 | 7.17 | 722,068 |
| May 2, 2025 | 7.53 | 7.62 | 7.25 | 7.30 | 7.30 | 1,060,189 |
| May 1, 2025 | 7.30 | 7.54 | 7.27 | 7.48 | 7.48 | 1,317,843 |
| Apr 30, 2025 | 7.50 | 7.63 | 7.23 | 7.29 | 7.29 | 1,331,018 |
| Apr 29, 2025 | 7.78 | 7.82 | 7.57 | 7.60 | 7.60 | 1,019,972 |
| Apr 28, 2025 | 7.77 | 7.86 | 7.69 | 7.77 | 7.77 | 565,057 |
| Apr 25, 2025 | 7.73 | 8.02 | 7.73 | 7.79 | 7.79 | 1,020,488 |
| Apr 24, 2025 | 7.63 | 7.79 | 7.56 | 7.79 | 7.79 | 814,155 |
| Apr 23, 2025 | 7.75 | 7.89 | 7.61 | 7.62 | 7.62 | 992,478 |
| Apr 22, 2025 | 7.55 | 7.73 | 7.43 | 7.68 | 7.68 | 1,047,678 |
| Apr 21, 2025 | 7.37 | 7.64 | 7.27 | 7.44 | 7.44 | 734,658 |
| Apr 17, 2025 | 7.33 | 7.54 | 7.33 | 7.43 | 7.43 | 616,535 |
| Apr 16, 2025 | 7.45 | 7.47 | 7.28 | 7.37 | 7.37 | 608,403 |
| Apr 15, 2025 | 7.42 | 7.63 | 7.41 | 7.54 | 7.54 | 845,832 |
| Apr 14, 2025 | 7.33 | 7.46 | 7.24 | 7.40 | 7.40 | 829,706 |
| Apr 11, 2025 | 6.90 | 7.20 | 6.77 | 7.16 | 7.16 | 1,110,747 |
| Apr 10, 2025 | 6.78 | 7.02 | 6.70 | 6.91 | 6.91 | 1,078,520 |
| Apr 9, 2025 | 6.32 | 7.10 | 6.13 | 6.92 | 6.92 | 1,686,218 |
| Apr 8, 2025 | 6.84 | 6.91 | 6.34 | 6.39 | 6.39 | 1,343,957 |
| Apr 7, 2025 | 6.65 | 6.91 | 6.42 | 6.66 | 6.66 | 2,050,191 |
| Apr 4, 2025 | 7.28 | 7.31 | 6.77 | 6.86 | 6.86 | 3,923,746 |
| Apr 3, 2025 | 7.68 | 7.68 | 7.35 | 7.37 | 7.37 | 1,013,544 |
| Apr 2, 2025 | 7.82 | 7.97 | 7.70 | 7.77 | 7.77 | 823,425 |
| Apr 1, 2025 | 7.96 | 7.96 | 7.72 | 7.86 | 7.86 | 1,305,276 |
| Mar 31, 2025 | 8.11 | 8.11 | 7.89 | 7.95 | 7.95 | 1,598,348 |
| Mar 28, 2025 | 8.69 | 8.81 | 8.23 | 8.28 | 8.28 | 855,644 |
| Mar 27, 2025 | 8.57 | 8.71 | 8.53 | 8.66 | 8.66 | 956,336 |
| Mar 26, 2025 | 8.57 | 8.68 | 8.40 | 8.60 | 8.60 | 1,945,187 |
| Mar 25, 2025 | 8.05 | 8.55 | 7.99 | 8.53 | 8.53 | 1,794,515 |
| Mar 24, 2025 | 8.15 | 8.26 | 8.09 | 8.21 | 8.21 | 896,346 |
| Mar 21, 2025 | 7.94 | 8.24 | 7.94 | 8.10 | 8.10 | 1,038,579 |
| Mar 20, 2025 | 8.04 | 8.11 | 7.94 | 8.01 | 8.01 | 493,019 |
| Mar 19, 2025 | 7.86 | 8.11 | 7.84 | 8.06 | 8.06 | 746,028 |
| Mar 18, 2025 | 7.96 | 8.01 | 7.81 | 7.86 | 7.86 | 592,549 |
| Mar 17, 2025 | 7.72 | 8.22 | 7.70 | 8.02 | 8.02 | 1,208,122 |
| Mar 14, 2025 | 7.88 | 8.00 | 7.66 | 7.72 | 7.72 | 895,095 |
| Mar 13, 2025 | 7.64 | 7.92 | 7.62 | 7.85 | 7.85 | 1,254,325 |
| Mar 12, 2025 | 7.46 | 7.79 | 7.37 | 7.69 | 7.69 | 1,803,217 |
| Mar 11, 2025 | 7.14 | 7.42 | 6.98 | 7.40 | 7.40 | 1,763,876 |
| Mar 10, 2025 | 7.44 | 7.50 | 7.18 | 7.27 | 7.27 | 1,302,694 |
| Mar 7, 2025 | 7.58 | 7.58 | 7.40 | 7.50 | 7.50 | 1,053,598 |
| Mar 6, 2025 | 7.46 | 7.63 | 7.45 | 7.58 | 7.58 | 1,266,436 |
| Mar 5, 2025 | 7.16 | 7.56 | 7.07 | 7.55 | 7.55 | 2,120,760 |
| Mar 4, 2025 | 7.15 | 7.34 | 7.12 | 7.32 | 7.32 | 1,599,528 |
| Mar 3, 2025 | 7.30 | 7.31 | 7.15 | 7.20 | 7.20 | 1,415,335 |
| Feb 28, 2025 | 7.19 | 7.32 | 7.07 | 7.30 | 7.30 | 1,848,150 |
| Feb 27, 2025 | 7.17 | 7.51 | 7.17 | 7.19 | 7.19 | 621,085 |
| Feb 26, 2025 | 7.28 | 7.41 | 7.14 | 7.17 | 7.17 | 1,039,686 |
| Feb 25, 2025 | 7.46 | 7.50 | 7.15 | 7.34 | 7.34 | 1,188,478 |
| Feb 24, 2025 | 7.35 | 7.52 | 7.09 | 7.49 | 7.49 | 1,588,735 |
| Feb 21, 2025 | 7.25 | 7.55 | 7.15 | 7.31 | 7.31 | 1,928,064 |
| Feb 20, 2025 | 7.04 | 7.22 | 7.00 | 7.15 | 7.15 | 2,181,043 |
| Feb 19, 2025 | 7.15 | 7.18 | 7.02 | 7.04 | 7.04 | 1,012,548 |
| Feb 18, 2025 | 7.24 | 7.26 | 7.12 | 7.18 | 7.18 | 1,993,826 |
| Feb 14, 2025 | 7.20 | 7.22 | 7.11 | 7.14 | 7.14 | 1,963,513 |
| Feb 13, 2025 | 7.22 | 7.25 | 6.99 | 7.18 | 7.18 | 1,698,442 |
| Feb 12, 2025 | 7.15 | 7.25 | 7.08 | 7.16 | 7.16 | 1,789,714 |
| Feb 11, 2025 | 7.18 | 7.25 | 7.08 | 7.19 | 7.19 | 2,079,229 |
| Feb 10, 2025 | 7.35 | 7.42 | 7.25 | 7.26 | 7.26 | 1,777,579 |
| Feb 7, 2025 | 7.26 | 7.31 | 7.20 | 7.25 | 7.25 | 1,222,927 |
| Feb 6, 2025 | 7.30 | 7.32 | 7.19 | 7.28 | 7.28 | 1,850,940 |
| Feb 5, 2025 | 7.28 | 7.30 | 7.16 | 7.26 | 7.26 | 1,894,256 |
| Feb 4, 2025 | 7.31 | 7.31 | 7.18 | 7.24 | 7.24 | 1,601,557 |
| Feb 3, 2025 | 7.15 | 7.30 | 6.99 | 7.26 | 7.26 | 1,406,348 |
| Jan 31, 2025 | 7.39 | 7.39 | 7.16 | 7.25 | 7.25 | 1,491,292 |
| Jan 30, 2025 | 7.40 | 7.41 | 7.29 | 7.35 | 7.35 | 1,613,288 |
| Jan 29, 2025 | 7.27 | 7.46 | 7.27 | 7.33 | 7.33 | 2,086,218 |
| Jan 28, 2025 | 7.45 | 7.53 | 7.31 | 7.35 | 7.35 | 959,882 |
| Jan 27, 2025 | 7.27 | 7.59 | 7.20 | 7.44 | 7.44 | 4,142,682 |
| Jan 24, 2025 | 7.02 | 7.10 | 6.91 | 7.10 | 7.10 | 1,537,197 |
| Jan 23, 2025 | 7.02 | 7.10 | 6.87 | 7.02 | 7.02 | 1,091,100 |
| Jan 22, 2025 | 6.95 | 7.10 | 6.88 | 7.01 | 7.01 | 1,285,166 |
| Jan 21, 2025 | 7.07 | 7.11 | 6.71 | 6.94 | 6.94 | 2,063,943 |
| Jan 17, 2025 | 7.02 | 7.19 | 6.88 | 7.08 | 7.08 | 4,917,688 |
| Jan 16, 2025 | 7.30 | 7.30 | 6.75 | 6.97 | 6.97 | 6,054,510 |
| Jan 15, 2025 | 7.57 | 7.61 | 7.20 | 7.26 | 7.26 | 4,397,173 |
| Jan 14, 2025 | 7.53 | 7.65 | 7.41 | 7.44 | 7.44 | 4,004,382 |
| Jan 13, 2025 | 7.70 | 7.88 | 7.36 | 7.50 | 7.50 | 12,090,986 |
| Jan 10, 2025 | 5.66 | 5.70 | 5.45 | 5.55 | 5.55 | 2,168,557 |
| Jan 8, 2025 | 5.94 | 6.05 | 5.72 | 5.85 | 5.85 | 723,000 |
| Jan 7, 2025 | 6.29 | 6.54 | 5.97 | 5.98 | 5.98 | 648,207 |
| Jan 6, 2025 | 6.21 | 6.53 | 6.08 | 6.22 | 6.22 | 953,953 |
| Jan 3, 2025 | 5.81 | 6.14 | 5.81 | 6.14 | 6.14 | 1,319,724 |
| Jan 2, 2025 | 5.54 | 5.88 | 5.40 | 5.78 | 5.78 | 2,506,372 |
| Dec 31, 2024 | 5.43 | 5.53 | 5.30 | 5.43 | 5.43 | 613,261 |
| Dec 30, 2024 | 5.40 | 5.49 | 5.24 | 5.43 | 5.43 | 804,406 |
| Dec 27, 2024 | 5.71 | 5.97 | 5.33 | 5.54 | 5.54 | 1,180,032 |
| Dec 26, 2024 | 5.46 | 5.80 | 5.27 | 5.73 | 5.73 | 1,798,716 |
| Dec 24, 2024 | 5.46 | 5.50 | 5.09 | 5.48 | 5.48 | 1,812,994 |
| Dec 23, 2024 | 5.57 | 5.76 | 5.36 | 5.44 | 5.44 | 3,972,023 |
| Dec 20, 2024 | 5.06 | 5.62 | 4.95 | 5.61 | 5.61 | 4,337,638 |
| Dec 19, 2024 | 5.11 | 5.16 | 4.96 | 5.00 | 5.00 | 1,168,492 |
| Dec 18, 2024 | 5.32 | 5.38 | 4.94 | 5.03 | 5.03 | 1,357,186 |
| Dec 17, 2024 | 5.29 | 5.48 | 5.07 | 5.27 | 5.27 | 1,170,202 |
| Dec 16, 2024 | 5.32 | 5.54 | 5.17 | 5.34 | 5.34 | 1,161,231 |
| Dec 13, 2024 | 5.66 | 5.72 | 5.03 | 5.38 | 5.38 | 1,742,024 |
| Dec 12, 2024 | 5.73 | 5.76 | 5.54 | 5.67 | 5.67 | 1,631,834 |
| Dec 11, 2024 | 5.61 | 5.91 | 5.51 | 5.89 | 5.89 | 776,037 |
| Dec 10, 2024 | 5.50 | 5.69 | 5.42 | 5.57 | 5.57 | 913,811 |
| Dec 9, 2024 | 5.68 | 5.80 | 5.54 | 5.56 | 5.56 | 804,922 |
| Dec 6, 2024 | 5.60 | 5.81 | 5.50 | 5.61 | 5.61 | 850,273 |
| Dec 5, 2024 | 5.52 | 5.82 | 5.52 | 5.60 | 5.60 | 865,045 |
| Dec 4, 2024 | 5.67 | 5.79 | 5.58 | 5.61 | 5.61 | 755,339 |
| Dec 3, 2024 | 5.78 | 5.78 | 5.53 | 5.60 | 5.60 | 672,750 |
| Dec 2, 2024 | 5.47 | 5.83 | 5.45 | 5.79 | 5.79 | 972,431 |
| Nov 29, 2024 | 5.50 | 5.59 | 5.42 | 5.47 | 5.47 | 329,870 |
| Nov 27, 2024 | 5.78 | 5.91 | 5.48 | 5.55 | 5.55 | 581,359 |
| Nov 26, 2024 | 5.32 | 5.78 | 5.16 | 5.76 | 5.76 | 725,044 |
| Nov 25, 2024 | 5.20 | 5.48 | 5.19 | 5.28 | 5.28 | 993,973 |
| Nov 22, 2024 | 4.85 | 5.21 | 4.85 | 5.17 | 5.17 | 871,036 |
| Nov 21, 2024 | 5.02 | 5.19 | 4.80 | 4.85 | 4.85 | 1,485,496 |
| Nov 20, 2024 | 4.75 | 5.13 | 4.62 | 4.91 | 4.91 | 1,586,378 |
| Nov 19, 2024 | 4.74 | 4.95 | 4.70 | 4.91 | 4.91 | 931,376 |
| Nov 18, 2024 | 5.06 | 5.09 | 4.74 | 4.78 | 4.78 | 860,815 |
| Nov 15, 2024 | 5.44 | 5.44 | 5.03 | 5.10 | 5.10 | 1,180,706 |
| Nov 14, 2024 | 5.87 | 5.87 | 5.34 | 5.37 | 5.37 | 892,362 |
| Nov 13, 2024 | 5.71 | 5.86 | 5.63 | 5.73 | 5.73 | 500,589 |
| Nov 12, 2024 | 6.23 | 6.28 | 5.73 | 5.73 | 5.73 | 563,655 |
| Nov 11, 2024 | 6.46 | 6.65 | 6.29 | 6.30 | 6.30 | 518,533 |
| Nov 8, 2024 | 6.33 | 6.39 | 6.17 | 6.31 | 6.31 | 438,774 |
| Nov 7, 2024 | 5.96 | 6.42 | 5.86 | 6.32 | 6.32 | 632,071 |
| Nov 6, 2024 | 6.27 | 6.44 | 5.92 | 5.95 | 5.95 | 786,119 |
| Nov 5, 2024 | 5.67 | 5.95 | 5.64 | 5.94 | 5.94 | 575,233 |
| Nov 4, 2024 | 5.92 | 6.12 | 5.80 | 5.81 | 5.81 | 735,618 |
| Nov 1, 2024 | 6.09 | 6.16 | 5.83 | 6.05 | 6.05 | 1,060,733 |
| Oct 31, 2024 | 6.39 | 6.59 | 5.92 | 6.08 | 6.08 | 1,381,926 |
| Oct 30, 2024 | 7.69 | 7.96 | 6.20 | 6.44 | 6.44 | 2,312,386 |
| Oct 29, 2024 | 8.53 | 8.70 | 8.34 | 8.48 | 8.48 | 861,673 |
| Oct 28, 2024 | 8.10 | 8.62 | 8.10 | 8.54 | 8.54 | 992,055 |
| Oct 25, 2024 | 7.89 | 8.16 | 7.84 | 8.01 | 8.01 | 661,812 |
| Oct 24, 2024 | 7.68 | 7.95 | 7.57 | 7.85 | 7.85 | 660,206 |
| Oct 23, 2024 | 7.59 | 7.72 | 7.33 | 7.65 | 7.65 | 551,560 |
| Oct 22, 2024 | 7.80 | 7.83 | 7.45 | 7.65 | 7.65 | 534,585 |
| Oct 21, 2024 | 7.55 | 7.81 | 7.41 | 7.79 | 7.79 | 613,908 |
| Oct 18, 2024 | 7.23 | 7.57 | 7.15 | 7.57 | 7.57 | 441,422 |
| Oct 17, 2024 | 7.25 | 7.32 | 6.63 | 7.21 | 7.21 | 715,218 |
| Oct 16, 2024 | 6.91 | 7.30 | 6.91 | 7.27 | 7.27 | 407,961 |
| Oct 15, 2024 | 6.87 | 7.04 | 6.82 | 6.86 | 6.86 | 357,395 |
| Oct 14, 2024 | 6.57 | 6.82 | 6.50 | 6.81 | 6.81 | 761,670 |
| Oct 11, 2024 | 6.33 | 6.78 | 6.20 | 6.59 | 6.59 | 659,917 |
| Oct 10, 2024 | 6.41 | 6.50 | 6.28 | 6.37 | 6.37 | 504,151 |
| Oct 9, 2024 | 6.26 | 6.79 | 6.26 | 6.49 | 6.49 | 919,448 |
| Oct 8, 2024 | 6.00 | 6.90 | 5.84 | 6.43 | 6.43 | 751,232 |
| Oct 7, 2024 | 6.58 | 6.74 | 6.45 | 6.72 | 6.72 | 462,328 |
| Oct 4, 2024 | 6.63 | 7.04 | 6.47 | 6.64 | 6.64 | 867,457 |
| Oct 3, 2024 | 6.95 | 7.03 | 6.72 | 6.99 | 6.99 | 415,424 |
| Oct 2, 2024 | 6.90 | 7.07 | 6.80 | 6.98 | 6.98 | 411,575 |
| Oct 1, 2024 | 7.15 | 7.15 | 6.89 | 6.96 | 6.96 | 624,201 |
| Sep 30, 2024 | 7.21 | 7.48 | 7.01 | 7.22 | 7.22 | 489,898 |
| Sep 27, 2024 | 7.26 | 7.50 | 7.25 | 7.29 | 7.29 | 313,101 |
| Sep 26, 2024 | 7.10 | 7.23 | 7.00 | 7.17 | 7.17 | 462,923 |
| Sep 25, 2024 | 7.35 | 7.47 | 6.98 | 7.02 | 7.02 | 682,260 |
| Sep 24, 2024 | 7.31 | 7.37 | 7.10 | 7.31 | 7.31 | 844,797 |
| Sep 23, 2024 | 7.53 | 7.53 | 7.11 | 7.23 | 7.23 | 1,013,692 |
| Sep 20, 2024 | 8.00 | 8.00 | 7.45 | 7.50 | 7.50 | 1,163,322 |
| Sep 19, 2024 | 7.86 | 8.05 | 7.65 | 7.90 | 7.90 | 627,180 |
| Sep 18, 2024 | 7.49 | 7.85 | 7.32 | 7.59 | 7.59 | 652,944 |
| Sep 17, 2024 | 7.63 | 7.82 | 7.49 | 7.52 | 7.52 | 379,642 |
| Sep 16, 2024 | 7.87 | 7.87 | 7.46 | 7.57 | 7.57 | 408,233 |
| Sep 13, 2024 | 7.50 | 7.85 | 7.43 | 7.83 | 7.83 | 523,447 |
| Sep 12, 2024 | 7.52 | 7.52 | 7.27 | 7.36 | 7.36 | 469,424 |
| Sep 11, 2024 | 7.32 | 7.51 | 7.23 | 7.49 | 7.49 | 607,478 |
| Sep 10, 2024 | 7.44 | 7.55 | 7.19 | 7.35 | 7.35 | 394,221 |
| Sep 9, 2024 | 7.42 | 7.59 | 7.28 | 7.44 | 7.44 | 647,100 |
| Sep 6, 2024 | 7.59 | 7.72 | 7.43 | 7.50 | 7.50 | 667,173 |
| Sep 5, 2024 | 8.07 | 8.11 | 7.63 | 7.64 | 7.64 | 720,566 |
| Sep 4, 2024 | 7.90 | 8.13 | 7.73 | 8.00 | 8.00 | 1,269,307 |
| Sep 3, 2024 | 8.30 | 8.46 | 7.82 | 7.91 | 7.91 | 740,969 |
| Aug 30, 2024 | 8.16 | 8.46 | 7.99 | 8.43 | 8.43 | 531,220 |
| Aug 29, 2024 | 7.97 | 8.31 | 7.91 | 8.09 | 8.09 | 530,758 |
| Aug 28, 2024 | 8.00 | 8.12 | 7.78 | 7.90 | 7.90 | 511,861 |
| Aug 27, 2024 | 8.18 | 8.34 | 7.90 | 8.11 | 8.11 | 516,669 |
| Aug 26, 2024 | 8.48 | 8.48 | 8.20 | 8.28 | 8.28 | 445,550 |
| Aug 23, 2024 | 8.31 | 8.49 | 8.13 | 8.41 | 8.41 | 525,260 |
| Aug 22, 2024 | 8.65 | 8.69 | 8.16 | 8.19 | 8.19 | 587,737 |
| Aug 21, 2024 | 8.39 | 8.69 | 8.31 | 8.65 | 8.65 | 523,958 |
| Aug 20, 2024 | 8.75 | 8.76 | 8.30 | 8.35 | 8.35 | 544,638 |
| Aug 19, 2024 | 8.17 | 8.76 | 8.10 | 8.74 | 8.74 | 673,575 |
| Aug 16, 2024 | 8.26 | 8.40 | 8.06 | 8.14 | 8.14 | 752,320 |
| Aug 15, 2024 | 8.19 | 8.64 | 8.08 | 8.30 | 8.30 | 587,754 |
| Aug 14, 2024 | 8.21 | 8.21 | 7.87 | 8.02 | 8.02 | 575,302 |
| Aug 13, 2024 | 7.94 | 8.25 | 7.79 | 8.14 | 8.14 | 608,952 |
| Aug 12, 2024 | 8.01 | 8.03 | 7.70 | 7.86 | 7.86 | 633,422 |
| Aug 9, 2024 | 8.25 | 8.29 | 7.98 | 8.01 | 8.01 | 495,820 |
| Aug 8, 2024 | 8.40 | 8.54 | 8.22 | 8.28 | 8.28 | 655,661 |
| Aug 7, 2024 | 8.88 | 8.88 | 8.29 | 8.31 | 8.31 | 661,381 |
| Aug 6, 2024 | 8.89 | 8.98 | 8.51 | 8.53 | 8.53 | 721,973 |
| Aug 5, 2024 | 8.83 | 9.07 | 8.52 | 8.96 | 8.96 | 1,209,622 |
| Aug 2, 2024 | 9.53 | 9.66 | 9.31 | 9.60 | 9.60 | 1,261,262 |
| Aug 1, 2024 | 10.66 | 10.74 | 9.49 | 9.76 | 9.76 | 1,350,882 |
| Jul 31, 2024 | 11.12 | 11.44 | 10.57 | 10.95 | 10.95 | 1,032,556 |
| Jul 30, 2024 | 10.23 | 10.87 | 10.19 | 10.80 | 10.80 | 852,677 |
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
Need daily prices for every ticker, in code?
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver API
SAGE Executive Compensation
We estimate that -- received a compensation of -- in --, making them the highest paid executive at SAGE, per a recent SEC DEF 14A filing.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|